Zdrowie i gospodarka · 26/06/2025
FDA Releases Final Guidance for Early Lyme Disease Treatment Drugs
The FDA has released a final guidance for the development of drugs to treat early Lyme disease, specifically erythema migrans, to assist pharmaceutical companies in clinical trials. The guidance finalizes a draft released in February 2023.